
    
      This trial is a single centre, open-label, randomised 4 period cross-over trial, comparing
      the pk and pd profiles of IAsp, BIAsp 30, BIAsp 50 and BIAsp 70 after a standard test meal in
      subjects with type 1 diabetes. The profiles will be derived over a 12-hour period after
      subcutaneous injection in the abdominal region with a single dose of IAsp, BIAsp 30, BIAsp 50
      or BIAsp 70 at a test meal. The trial consists of a screening period of 4-21 days and 4
      treatment visits
    
  